U.N. creates new Ebola chief role to tackle security, political issues in Congo
GENEVA (Reuters) – The United Nations named an Emergency Ebola Response Coordinator on Thursday, creating a new position to boost…
Exclusive: JPMorgan cuts ties with OxyContin maker Purdue Pharma – sources
(Reuters) – JPMorgan Chase & Co has cut ties with Purdue Pharma LP over the OxyContin maker’s alleged role in…
Novartis CEO plans gene therapy price ‘far lower’ than $4 million to $5 million range
FILE PHOTO: The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017.…
U.S. measles outbreak grows with 75 new cases, mostly in New York
FILE PHOTO – One-year-old Bella Huang cries as medical assistants secure her legs for a series of vaccines at the…
U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit
WASHINGTON (Reuters) – U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19…
U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit
WASHINGTON (Reuters) – U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19…
Many U.S. allergists now prescribe tablets instead of shots
(Reuters Health) – Almost three in four U.S. allergy specialists are prescribing tablets to ease symptoms caused by pollen, ragweed…
FDA grants Jacobus Pharma approval for rare disease drug
(Reuters) – Jacobus Pharmaceutical Co Inc on Monday won U.S. approval for the first drug to treat children with Lambert-Eaton…
Patients’ drug costs surge for some neurologic conditions
(Reuters Health) – Many patients with neurologic disorders like multiple sclerosis, epilepsy and Parkinson’s disease have seen steep increases in…
The obscure advisory committees at the heart of the U.S. drug pricing debate
CHICAGO (Reuters) – Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli…
FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug
(Reuters) – The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc’s cholesterol drug Praluent as a treatment…
Trump says he is holding big Pharma accountable in opioid fight
ATLANTA (Reuters) – U.S. President Donald Trump touted progress in the fight against opioid abuse on Wednesday and promised to…
Walgreens, Rite Aid set minimum age to sell tobacco products at 21 years
(Reuters) – Drugstore retailers Walgreens Boots Alliance Inc and Rite Aid Corp will no longer sell tobacco products to customers…
Walgreens, Rite Aid set minimum age to sell tobacco products at 21 years
(Reuters) – Drugstore retailers Walgreens Boots Alliance Inc and Rite Aid Corp will no longer sell tobacco products to customers…
Merck’s Keytruda wins FDA approval as combination therapy for kidney cancer
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey,…
CDC reports 71 new measles cases in a week
FILE PHOTO: A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30,…
Second death in Novartis gene therapy trials under investigation
(Reuters) – Novartis AG, which this week announced positive interim trial results for its experimental gene therapy for spinal muscular…
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet…
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet…
U.S. measles cases surge nearly 20 percent in early April, CDC says
(Reuters) – The number of confirmed cases of measles in the United States this year jumped by nearly 20 percent…
Catalent seeks slice of gene therapy market with Paragon buy
(Reuters) – Contract drugmaker Catalent Inc said on Monday it would buy privately held Paragon Bioservices Inc for $1.2 billion…
Zogenix’s seizure drug filing fails to pass U.S. FDA scrutiny
(Reuters) – The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix Inc’s…
Oklahoma drops several claims in opioid case against J&J, Teva
(Reuters) – Oklahoma’s attorney general on Thursday had dropped all but a single claim against Johnson & Johnson and Teva…
Purdue Pharma agrees to $270 million settlement in Oklahoma opioid case
(Reuters) – OxyContin maker Purdue Pharma LP and members of the wealthy Sackler family that own the company reached a…
OxyContin maker Purdue agrees to settle Oklahoma opioid case: source
(Reuters) – Purdue Pharma LP has agreed to settle a lawsuit by the state of Oklahoma accusing the OxyContin painkiller…
FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes
(Reuters) – The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals…
Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value
CHICAGO/TOKYO (Reuters) – Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease…
Jazz Pharma’s sleep disorder treatment gets FDA nod
(Reuters) – The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc’s treatment for patients with a form of sleep…
Amarin’s Vascepa cuts occurrence of serious heart problems 30 percent: study
(Reuters) – A high dose of Amarin Corp’s Omega-3 drug Vascepa significantly reduced the occurrence of first and subsequent heart…
WHO says Ebola area contained but Congo needs long-term support
GENEVA (Reuters) – The Ebola outbreak in Democratic Republic of Congo is now concentrated in two areas and could be…
FDA approves generic valsartan amid drug shortage
(Reuters) – The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood…
FDA approves Pfizer’s biosimilar to Roche’s Herceptin
FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2,…
J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it approved a Johnson & Johnson nasal spray antidepressant…
Allergan’s add-on treatment for depression fails late-stage studies
FILE PHOTO: The Allergan logo is seen in this photo illustration November 23, 2015. To match special report USA-FDA/CASES REUTERS/Thomas…
FDA chief tough on e-cigs steps down in surprise resignation
WASHINGTON (Reuters) – U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down…
Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy – sources
(Reuters) – OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from roughly 2,000…
Eli Lilly seeks to quell drug price anger with cheaper insulin
(Reuters) – Drugmaker Eli Lilly announced plans on Monday to sell a half-price version of its popular insulin injection Humalog,…
New cancer-causing toxin found in recalled blood pressure pills
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled…
U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug
(Reuters) – U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost…
Vaginal laser treatment tied to complications like scarring
(Reuters Health) – Vaginal laser treatments may help relieve problems associated with menopause, like dryness, pain and sexual dysfunction, but…
Brazil health agency concludes safety evaluation of weedkiller glyphosate
BRASILIA (Reuters) – Brazil’s health agency has concluded a re-evaluation of the safety of the weedkiller glyphosate, the most widely-used…
Novartis gene therapy would be cost effective up to $900,000: U.S. group
(Reuters) – An experimental gene therapy for spinal muscular atrophy (SMA) developed by Swiss drugmaker Novartis AG would be worth…
U.S. settles with Teva over keeping generic drugs off market
FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference hold by its CEO, Kare Schultz,…
As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices
TOKYO (Reuters) – Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether taxpayers…
Aggressive sanitizing at home lowers post-hospital MRSA risk
(Reuters Health) – A six-month program of aggressively washing and sanitizing at home after surgery can lower the risk of…
Merck, Pfizer combo treatment boosts kidney cancer survival
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey,…
J&J becomes first drugmaker to add prices to television ads
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo CHICAGO…
Sanofi blood disorder drug wins FDA approval
(Reuters) – The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Sanofi SA’s drug to treat…
Merck CEO Frazier to testify at Senate drug pricing hearing
NEW YORK/WASHINGTON (Reuters) – U.S. drugmaker Merck & Co Inc said on Tuesday that its Chief Executive Ken Frazier plans…
Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva
NEW YORK (Reuters) – A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine…
FDA approves cheaper Botox rival to treat frown lines
(Reuters) – An injection that makes forehead wrinkles disappear is set to rival Allergan’s Botox after U.S. regulators approved Evolus…
Pregnant women with severe flu more likely to have poor outcomes
(Reuters Health) – Pregnant women so sick with influenza that they’re admitted to the intensive care unit (ICU) are more…
Insys founder ran bribe scheme to push opioid: U.S. prosecutor
BOSTON (Reuters) – Insys Therapeutics Inc’s one-time billionaire founder directed a vast scheme to bribe doctors to prescribe an addictive…
Ebola spreads to high-risk area of Congo: WHO
GENEVA (Reuters) – Democratic Republic of Congo’s Ebola outbreak has spread southwards into an area with high security risks, the…
Italy drugmaker Zambon ready to splash out in U.S., China push
MILAN (Reuters) – Italian drugmaker Zambon is looking to China and the U.S. to grow its respiratory and nervous system…
Not-for-profit to offer 20 generic drugs in 2019 to alleviate shortages
(Reuters) – A new not-for-profit supplier of generic drugs formed by a consortium of hospitals systems said it expects this…
J&J, U.S. states settle hip implant claims for $120 million
(Reuters) – Johnson & Johnson and its DePuy Orthopaedics unit have agreed to pay $120 million to resolve deceptive marketing…
Rotavirus vaccination tied to lower rates of type 1 diabetes
(Reuters Health) – Young kids who receive the rotavirus vaccine may be less likely to develop type 1 diabetes than…
Swiss team develop ‘microswimmer’ robot to deliver drugs through the body
LONDON (Reuters) – – A tiny sliver of elastic material swims along inside a narrow tube, coiling up and changing…